Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Biophytis SA ( (FR:ALBPS) ) is now available.
Biophytis SA has completed the settlement and delivery of a private placement valued at approximately 2.6 million euros. This financial maneuver involved the issuance of new ordinary shares and pre-funded warrants, which have been admitted to trading on Euronext Growth. The successful placement, facilitated by Maxim Group LLC and Invest Securities, is expected to enhance Biophytis’s financial position, potentially impacting its operations and market strategy in developing treatments for age-related diseases.
More about Biophytis SA
Biophytis SA is a clinical-stage biotechnology company focused on developing treatments for age-related diseases. The company operates in the biotechnology industry and is listed on Euronext Growth Paris.
YTD Price Performance: -43.43%
Average Trading Volume: 17,907
Technical Sentiment Signal: Buy
Current Market Cap: €3.18M
For detailed information about ALBPS stock, go to TipRanks’ Stock Analysis page.